Canada Algernon receives approval to conduct DMT study in the Netherlands New clinical research will assess efficacy of IV formulation for the treatment of strokes Rowan DunneSeptember 12, 2022
Cannabis Pot exposure during pregnancy associated with some mental disorders in young teens: NIH study The authors say the results of this new analysis further support caution against using cannabis during pregnancy Natalia Buendia CalvilloSeptember 12, 2022
News Psilocybin more efficient for rumination than common antidepressant: study The study assessed differences between psilocybin and escitalopram on common signs in MDD Natalia Buendia CalvilloSeptember 9, 2022
Cannabis CBD usage booming among baby boomers: Stirling New statistics from CBD producer show that older generations prefer cannabinoid over traditional medicines Rowan DunneSeptember 8, 2022
Research Screen time before bed doesn’t necessarily mean poor sleep: study Melatonin decreased by 14% after being exposed to short wavelength light but participants saw no differences in their sleep quality Natalia Buendia CalvilloSeptember 7, 2022
Cannabis The lazy stoner myth debunked: University of Cambridge New research shows that there is no scientific basis for pervading stereotype Rowan DunneSeptember 7, 2022
Research Psychedelic use rising as the market expands: MicroSmallCap New report outlines statistics and recent accomplishments made in the field Rowan DunneSeptember 6, 2022
Canada Filament administers psilocybin to 14 participants in Health Canada sanctioned clinical trial Clinical trial will be conducted as part of the ATMA Journey Centre's psychedelic-assisted therapist training program Rowan DunneSeptember 1, 2022
Psychedelics Heroic Hearts collaborates with Maya to streamline psychedelic data for veterans Influencing policies, cataloguing proof of efficacy and assisting veterans integration processes will be ideal outcomes from partnership Rowan DunneSeptember 1, 2022
Psychedelics Beond publishes ‘Ibogaine: A Clinical Summary’ Mexican clinical practice releases 'most complete and up-to-date known summary' regarding plant-derived psychoactive substance Rowan DunneAugust 31, 2022